Leukemia Risk From MS Drug May Be Up
But few options require balancing dangers and benefits, experts say
Posted April 30, 2009
Those who took both drugs had 38 percent fewer relapses than did people who took only the interferon drug. They also improved slightly on a test of MS disability, whereas the scores for the interferon-only group decreased slightly.
The study was funded by Biogen-Idec, which makes Avonex.
More information
The National Multiple Sclerosis Society has more on MS.
advertisement
